Growth hormone releasing factor and assessment of growth hormone reserve in children

Pituitary somatotrophic reserve was assessed in children with growth delay using clofelin and growth hormone releasing factor (GH-RH). Thirty-four children hospitalized with suspected insufficiency of growth hormone (GH) were examined (22 boys and 12 girls aged 5.3 to 16.2, mean age 11.6±3.2). Bone age lagged behind the chronologic by 4.4+2.1 years, and signs of puberty were absent by the moment of hospitalization in all the children. Clofelin was administered orally in a dose of 0.15 microg/m2 body surface, GH-RH by intravenous jet in a dose of 1 mg/kg. The patients were divided into 3 groups with different response of GH to stimulation with clofelin and GH-RH: group A with a low GH output in both test (the pituitary form); group В with a low reaction to clofelin and normal response to GH-RH (the hypothalamic form); group C with increased level of response to both clofelin and GH-RH (idiopathic dwarfism). Group A included 14 children aged 11.7±2.9. Growth SDS in these children varied from -7.8 to -2.6 (-4.4±1.66). The maximal GH level after clofelin intake was 1.3 ± 1.6 ng/ml and after GH-RH infusion 3.5±2.51 ng/ml in group A. Group В consisted of 7 patients aged 12.0±4.4. Growth SDS in this group varied from -5.6 to 2.5 (- 4.0±1.3). The maximal level of GH in this group was 2.5±2.4 ng/ ml in clofelin test and 15.9±5.4 ng/ml in GH-RH test. Group C included 13 children aged 11.0±4.4, with growth SDS varying from -4.3 to -2.3 (-3.0±0.63). The maximal GH level after clofelin was 15.6±8.2 and after GH-RH 40.8±26.1 ng/ml, this being reliably higher than in group В (U=16.5, p=0.02). Hence, somatotrophic insufficiency was caused by hypothalamic disorders in approximately one-third of our patients.

1. Булатов А. А., Елизарова Г. И., Осипова Т. А., Киселева А. Г. // Гормон роста человека. — Пущино, 1988. С. 64— 68.

2. Albertsson-Wikland К, Rozberg S. // J. clin. Endocr. — 1988. — Vol. 67, N 4. — P. 493—500.

3. Barinaga M., Yamonoto G., Rivier C. et al. // Nature. — 1983. — Vol. 306. — P. 84—85.

4. Bercu В. B., Shulman D., Root A. W. et al. // J. clin. Endocr. — 1986. — Vol. 63. N 4. — P. 709—716.

5. Bowers C. Y, Alster D. K, Frentz J. M. // Ibid. — 1992. — Vol. 74, N 2. — P. 292—298.

6. Bowers C. Y. // J. pediat. Endocr. — 1993. — Vol. 6, N 1. — P. 21—31.

7. Brook C. G. D. A Guide to the Practice of Paediatric Endocrinology. — Cambridge, 1993.

8. Carlsson L. M., Attie K., Compton P. G. et al. // J. clin. Endocr. — 1994. — Vol. 78. — P. 1325—1330.

9. Cliatellain P., Alamercery Y., Blanchard J. et al. // Ibid. — Vol. 65. — P. 387—394.

10. Fukata J., Diamond D. J., Martin J. В. // Endocrinology. — 1985. — Vol. 117, N 4. — P. 457—467.

11. Guillemin R., Brazeau P., Bohlen P. et al. // Science. — 1982. — Vol. 218. — P. 585—587.

12. Hartman M. L., Veldhuis J. D., Thomer M.O. // Horm. Res. —1993. — Vol. 40. — P. 37—47.

13. Hopwood N.. Hintz R, Gertner J. et al. // J. Pediat. — 1993. —Vol. 123. — P. 215—222.

14. Momany F. A., Bowers C. Y., Reynolds G. A. et al. // Endocrinology. — 1980. — Vol. 108. — P. 31—39.

15. Muller E. E. // Physiol. Rev. — 1987. — Vol. 67, N 3. — P. 962—1053.

16. Neyzi O., Yordam N., Ocal G. et al. // Acta paediat. scand. — 1993. — Suppl. 388. — P. 16v21.

17. Ranke M. B. // Ibid. — 1991. — Suppl. 379. — P. 87-92.

18. Rivier J., Spiess J., Thomer M. et al. // Nature. — 1982. — Vol. 300. — P. 276—278.

19. Stefaneanu L., Kivacs K., Cronin M. J. et al. // Effect of Growth Hormone-Releasing Hormone (GRN) Infusion on Morphology of Rat Pituitary Somatotrophs. — Nice, 1992. — P. 289.